The Prevalence of Substance Abuse and its Relationship with Demographic Factors among Pregnant Women

Document Type : Original Article (s)

10.22122/jims.v39i617.13126

Abstract

Background: Substance abuse during pregnancy has serious side effects on mothers and her baby. The aim of this study was to determine the relative frequency of substance abuse in pregnant women in Isfahan City, Iran.
Methods: This was a cross-sectional analytical research. 400 pregnant women referred to midwifery clinics in Isfahan were randomly selected. Demographic data of pregnant women as well as the history of substance abuse were collected through face-to-face interviews using a researcher-made checklist. Substance abuse of pregnant women was assessed by urine screening tests.
Findings: In this study, 400 pregnant women with a mean age of 30.2 years were included. Urine sample test was negative for drugs or stimulants in 94.5% of mothers and positive in 5.5%. Pregnant women with a positive history of substance abuse had significant differences in terms of occupation, maternal smoking, spouse addiction, the presence of an addicted person in first-degree relatives, method of use in first-degree relatives, and positive urine test compared to pregnant mothers without substance abuse history.
Conclusion: The prevalence of substance abuse among pregnant women in Isfahan was estimated to be about 5.5% based on urine screening test. This is near the prevalence rate of substance abuse among pregnant women reported in other studies in the country. The frequency of positive urine test for substance abuse was higher than the frequency announced in face-to-face interviews with pregnant women.

Keywords

References

Savadzadeh S. Consulting addicted in women during pregnancy. Holist Nurs Midwifery 2008; 18(2): 44-50. [In Persian].
Kuczkowski KM. Cocaine abuse in pregnancy--anesthetic implications. Int J Obstet Anesth 2002; 11(3): 204-10.
Nikoo N, Frank A, Nikoo M, Jang K, Abrahams R, Krausz M. Health of pregnant women with substancerelated disorder, a neglected global health issue requiring combined maternity care units. Ment Health Fam Med 2015; 11: 26-35.
McHugh RK, Wigderson S, Greenfield SF. Epidemiology of substance use in reproductive-age women. Obstet Gynecol Clin North Am 2014; 41(2): 177-89.
Cortes L, Almeida L, Sabra S, Muniesa M, Busardo FP, Garcia-Algar O, et al. Maternal hair and neonatal meconium to assess gestational consumption and prenatal exposure to drugs of abuse and psychoactive drugs. Curr Pharm Biotechnol 2018; 19(2): 136-43.
De SM, De LC, Mappa I, Quattrocchi T, Angelo L, Cesari E. Smoke, alcohol consumption and illicit drug use in an Italian population of pregnant women. Eur J Obstet Gynecol Reprod Biol 2011; 159(1): 106-10.
Rausgaard NL, Ibsen IO, Jorgensen JS, Lamont RF, Ravn P. Prevalence of substance abuse in pregnancy among Danish women. Acta Obstet Gynecol Scand 2015; 94(2): 215-9.
Ramazanzadeh F, Tavafian S, Vahdaninia M, Shariat A, Montazeri A. Maternal and fetal outcomes of narcotic substance abuse, cigarette smoking, and unsafe drugs during pregnancy. Hakim Res J 2007; 10(3): 9-16. [In Persian].
Saleh GS, Fallahian M, Haghighi L, Hosseinnezhad-Yazdi M, Dashti E, Dolan K. Maternal and neonatal complications of substance abuse in Iranian pregnant women. Acta Med Iran 2012; 50(6): 411-6.
Soheili F, Alizadeh S, Darash M, Yousefi A, Cheraghi M, Asadollahi K. Prevalence of illegal drugs and alcohol during pregnancy in Ilam. Iran J Obstet Gynecol Infertil 2012; 15(3): 22-9. [In Persian].
Tavafian SS, Ramezan Zadeh F. Cigarette smoking, illicit medicine, substance and alcohol abuseamong pregnant women: A cross sectional study from Iran. Int J Fertil Steril 2008; 2(1): 35-8.
Torshizi M, Saadatjoo S, Farabi M. Prevalence of narcotic substance abuse and the maternal and fetal outcomes in pregnant women. J Jahrom Univ Med Sci 2011; 9(3): 14-9. [In Persian].
O'Donnell M, Nassar N, Leonard H, Hagan R, Mathews R, Patterson Y, et al. Increasing prevalence of neonatal withdrawal syndrome: Population study of maternal factors and child protection involvement. Pediatrics 2009; 123(4): e614-e621.
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. Williams Obstetrics.22th Eed. New York, NY: McGraw-Hill; 2005.
Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118(3): 1149-56.
Tabatabaei SM, Behmanesh-Pour F, Salimi-Khorashad A, Zaboli M, Sargazi-Moakhar Z, Shaare-Mollashahi S. Substance abuse and its associated factors among pregnant women: A cross-sectional study in the southeast of Iran. Addict Health 2018; 10(3): 162-72.
Bada HS, Das A, Bauer CR, Shankaran S, Lester B, Wright LL, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol 2002; 100(5 Pt 1): 916-24.
Grunbaum AM, Rainey PM. Laboratory principles. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank's toxicologic emergencie. 11th ed. New York, NY: McGraw-Hill; 2019. p. 71-2.
Sanaullah F, Gillian M, Lavin T. Screening of substance misuse during early pregnancy in Blyth: an anonymous unlinked study. J Obstet Gynaecol 2006; 26(3): 187-90.
National Institutes of Health. Prescription Drugs: Abuse and Addiction. Research Report Series. National Institue on Drug Abuse. Bethesda, MD: NIH; 2001.
Bessa MA, Mitsuhiro SS, Chalem E, Barros MC, Guinsburg R, Laranjeira R. Correlates of substance use during adolescent pregnancy in Sao Paulo, Brazil. Braz J Psychiatry 2010; 32(1): 66-9.
Garcia-Algar O, Vall CO, Puig SC, Mur SA, Scaravelli G, Pacifici R, et al. Prenatal exposure to drugs of abuse using meconium analysis in a low socioeconomic population in Barcelona. An Pediatr (Barc) 2009; 70(2): 151-8.
Journal of Isfahan Medical School
Volume 39, Issue 617
2021
Pages 167-173

Files

History

  • Receive Date: 01 April 2022
  • Accept Date: 01 April 2022

Share

How to cite

Statistics